Estimation of Anti-SARS-CoV-2 IgM/IgG Seroprevalence Among Non-Vaccinated and Vaccinated University Students: A Cross-Sectional Egyptian Study

被引:0
|
作者
Taha, Ahmed E. [1 ,2 ]
Amer, Ibrahim [3 ]
El Sharawy, Shimaa [4 ]
Ghazy, Amany A. [1 ]
机构
[1] Jouf Univ, Coll Med, Dept Pathol, Microbiol & Immunol Unit, Sakaka 72388, Saudi Arabia
[2] Mansoura Univ, Fac Med, Med Microbiol & Immunol Dept, Mansoura 35516, Egypt
[3] Kafr Elsheikh Univ, Fac Med, Dept Hepatol Gastroenterol & Infect Dis, Kafr Al Sheikh 33516, Egypt
[4] Tanta Univ, Fac Med, Dept Trop Med & Infect Dis, Tanta 31527, Egypt
来源
VIRUSES-BASEL | 2025年 / 17卷 / 03期
关键词
COVID-19; healthy; immunization; SARS-CoV-2; serological testing; vaccines; viruses; IMMUNE-RESPONSE; COVID-19; OBESITY; ANTIBODIES;
D O I
10.3390/v17030378
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
It is essential to comprehend the humoral immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its vaccines to maximize the effectiveness of anti-SARSCoV-2 community immunization efforts. The aim of this cross-sectional study was to determine the seroprevalence of anti-SARS-CoV-2 IgM/IgG among newcomer students at Kafr Elsheikh University in Egypt, whether they had been vaccinated or not. Blood samples from 400 healthy newcomer students (200 non-vaccinated and 200 vaccinated) were evaluated for the presence of anti-SARS-CoV-2 IgM/IgG using colloidal gold immunochromatography lateral flow immunoassay cards, and then the results were confirmed by using specific ELISA tests. The prevalence of anti-SARS-CoV-2 antibodies among the participants (n = 400) was 56.3% for IgG and 13.3% for IgM. Regarding the non-vaccinated participants, 55.0% were females, the mean age was 18.2 years, and the mean BMI was 25.35. Regarding the vaccinated participants, 58.5% were females, the mean age was 18.1 years, and the mean BMI was 25.3. There were statistically non-significant correlations (p > 0.05) between gender, BMI, and each of IgM- or IgG-positivity in both vaccinated and non-vaccinated groups. In total, 41.5% and 48.5% of the anti-SARS-CoV-2 IgM-positive and anti-SARS-CoV-2 IgG-positive participants were non-vaccinated, respectively. Furthermore, 58.5% and 51.5% of the anti-SARS-CoV-2 IgM-positive and anti-SARS-CoV-2 IgG-positive participants were vaccinated, respectively. No statistically significant association (p > 0.05) in immunoglobulins positivity between the anti-SARS-CoV-2 non-vaccinated, and vaccinated groups. The anti-SARS-CoV-2 immunological response of nonsmokers, people who exercise regularly, and those who take vitamin supplements, eat a balanced diet, and use certain herbs is noteworthy. Among the vaccinated subjects, 96.6%, 25.0%, 31.9%, 45.7%, and 7.8% of the IgG-positive group, versus 97.2%, 60.6%, 64.2%, 52.3%, and 6.4% of the IgG-positive non-vaccinated group, were nonsmokers, exercisers, and those taking vitamin supplements, eating a balanced diet, and using herbs, respectively. Furthermore, 93.5%, 32.3%, 35.5%, 48.4%, and 6.5% of the IgM-positive vaccinated group, versus 100.0%, 63.6%, 81.8%, 45.5%, and 4.5% of the IgM-positive non-vaccinated participants, were nonsmokers, physical exercisers, vitamin supplement users, balanced eaters, and herbalists, respectively. Persons who are free from comorbidities, young, non-obese, non-smokers, engage in physical exercise, take vitamins, eat a balanced diet, and use certain immunostimulant herbal supplements, all have a strong anti-SARS-CoV-2 humoral immune response, even if they were not vaccinated. During pandemics, vaccination of this group should not be a priority to preserve vaccine doses for high-risk vulnerable people. Even if there is a lockdown during an anticipated future epidemic or pandemic, we should prioritize healthy eating and lifestyle choices, along with increasing physical activity.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
    Kante, Bhaskar
    Vuyyuru, Sudheer Kumar
    Gupta, Ritu
    Dwivedi, Tanima
    Kumar, Peeyush
    Mundhra, Sandeep
    Golla, Rithvik
    Virmani, Shubi
    Verma, Mahak
    Makharia, Govind
    Ahuja, Vineet
    Kedia, Saurabh
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2023, 42 (01) : 70 - 78
  • [22] High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
    Bhaskar Kante
    Sudheer Kumar Vuyyuru
    Ritu Gupta
    Tanima Dwivedi
    Peeyush Kumar
    Sandeep Mundhra
    Rithvik Golla
    Shubi Virmani
    Mahak Verma
    Govind Makharia
    Vineet Ahuja
    Saurabh Kedia
    Indian Journal of Gastroenterology, 2023, 42 : 70 - 78
  • [23] Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data
    Perrella, Alessandro
    Bisogno, Massimo
    D'Argenzio, Angelo
    Trama, Ugo
    Coscioni, Enrico
    Orlando, Valentina
    HEALTHCARE, 2022, 10 (06)
  • [24] Accuracy of the serological detection of IgG and IgM to SARS-Cov-2: a prospective, cross-sectional study
    Pecoraro, Valentina
    Cassetti, Tiziana
    Meacci, Marisa
    Gargiulo, Raffaele
    Capobianchi, Maria Rosaria
    Mussini, Cristina
    Vecchi, Elena
    Pecorari, Monica
    Gagliotti, Carlo
    Trenti, Tommaso
    Sarti, Mario
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (09) : 1891 - 1898
  • [25] Accuracy of the serological detection of IgG and IgM to SARS-Cov-2: a prospective, cross-sectional study
    Valentina Pecoraro
    Tiziana Cassetti
    Marisa Meacci
    Raffaele Gargiulo
    Maria Rosaria Capobianchi
    Cristina Mussini
    Elena Vecchi
    Monica Pecorari
    Carlo Gagliotti
    Tommaso Trenti
    Mario Sarti
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 1891 - 1898
  • [26] Estimation of anti-SARS-CoV-2 IgG titre among blood donors in Ranchi
    Kumari, Sushma
    Saroj, Usha
    Verma, Ashwini
    Kumar, Abhay
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (10) : 6385 - 6389
  • [27] Seroprevalence of anti-SARS-CoV-2 antibodies in Indore, Madhya Pradesh: a community-based cross-sectional study, August 2020
    Sakalle, Salil
    Saroshe, Satish
    Shukla, Harish
    Mutha, Anita
    Vaze, Ameya
    Arora, Arpit
    Athotra, Aditya
    Ramaswamy, Sudarshan
    Jain, Arania
    Dhuria, Meera
    Patil, Anil D.
    Rai, Arvind
    Garg, Suneela
    Jain, Sudhir K.
    Bindal, Jyoti
    Singh, Sujeet K.
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (03) : 1479 - 1484
  • [28] Seroprevalence of anti-SARS-CoV-2 IgG among adolescents at military fitness-for-duty evaluation
    Giuliano, Elena
    Gennaro, V.
    Milani, G. P.
    Bianchetti, M.
    Kocher, C.
    Buehrer, T.
    Mathis, B.
    Togni, G.
    Muggli, F.
    BMJ MILITARY HEALTH, 2022, 168 (03) : 246 - +
  • [29] Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
    Lee, Yu-Lin
    Liao, Chia-Hung
    Liu, Po-Yu
    Cheng, Chien-Yu
    Chung, Ming-Yi
    Liu, Chun-Eng
    Chang, Sui-Yuan
    Hsueh, Po-Ren
    JOURNAL OF INFECTION, 2020, 81 (02) : E55 - E58
  • [30] Assessment of Anti-SARS-CoV-2 antibody levels among university students vaccinated with different COVID-19 primary and booster doses - fall 2021, Wisconsin
    DeJonge, Peter M.
    Lambrou, Anastasia S.
    Segaloff, Hannah E.
    Bateman, Allen
    Sterkel, Alana
    Griggs, Carol
    Baggott, Jake
    Kelly, Patrick
    Thornburg, Natalie
    Epperson, Monica
    Desamu-Thorpe, Rodel
    Abedi, Glen
    Hsu, Christopher H.
    Nakayama, Jasmine Y.
    Ruffin, Jasmine
    Turner-Harper, Darlene
    Matanock, Almea
    Almendares, Olivia
    Whaley, Melissa
    Chakrabarti, Ayan
    DeGruy, Kyle
    Daly, Michele
    Westergaard, Ryan
    Tate, Jacqueline E.
    Kirking, Hannah L.
    BMC INFECTIOUS DISEASES, 2023, 23 (01)